. This 2-volume masterwork remains the "gold standard" for infectious disease practitioners, updated by a new editorial team including
: Provides deep-dive coverage of next-generation sequencing , nucleic acid amplification, and novel treatments like monoclonal antibodies and phage therapy.
: Includes dedicated sections on SARS-CoV-2 (COVID-19) , anti-fungal therapy, bacteriophages, infections following traumatic injuries, and the impact of climate change on infectious diseases.
– eBook includes searchable content, downloadable images, and regular updates from the editors.
Elsevier
Published by Elsevier and selected as a Doody’s Core Title, this text spans more than 4,150 pages of dense, highly actionable clinical science. It serves as a vital bridge between basic microbiology laboratory breakthroughs and real-world bedside management. Core Specifications & Publication Overview
With the rise of multi-drug resistant (MDR) superbugs, the text introduces brand-new chapters detailing and related biological agents. It also provides deep coverage of monoclonal antibodies, novel antiviral matrices, and newly approved systemic antifungal therapies. 4. Climate Change and Environmental Vectors
As infectious disease threats shift, so does the content of this foundational text. The 10th edition features significant enhancements: 1. Updated Coverage of Emerging Pathogens
: A leading authority on viral pathogenesis and immunology from the National Institutes of Health (NIH).
Traditional culture techniques are contextualized alongside a heavy emphasis on , syndromic PCR panels, and Next-Generation Sequencing (NGS) . This allows clinicians to deploy rapid genomic sequencing directly for real-time pathogen identification. 3. Advanced Therapeutics and Phage Therapy